Goodman
-
Upload
angelo-hernandez -
Category
Documents
-
view
35 -
download
5
Transcript of Goodman
Cover Preface Preface to the Online Edition Copyright Information Contributors Contents 1. Drug Invention & the Pharmaceutical Industry 2. Pharmacokinetics: The Dynamics of Drug Absorption, Distribution,Metabolism & Elimination 3. Pharmacodynamics: Molecular Mechanisms of Drug Action 4. Drug Toxicity & Poisoning 5. Membrane Transporters & Drug Response 6. Drug Metabolism 7. Pharmacogenetics 8. Neurotransmission: The Autonomic & Somatic Motor NervousSystems 9. Muscarinic Receptor Agonists & Antagonists 10. Anticholinesterase Agents 11. Agents Acting at the Neuromuscular Junction & Autonomic Ganglia12. Adrenergic Agonists & Antagonists 13. 5-Hydroxytryptamine (Serotonin) & Dopamine 14. Neurotransmission & the Central Nervous System 15. Drug Therapy of Depression & Anxiety Disorders 16. Pharmacotherapy of Psychosis & Mania 17. Hypnotics & Sedatives 18. Opioids, Analgesia & Pain Management 19. General Anesthetics & Therapeutic Gases 20. Local Anesthetics 21. Pharmacotherapy of the Epilepsies 22. Treatment of Central Nervous System Degenerative Disorders
23. Ethanol & Methanol 24. Drug Addiction 25. Regulation of Renal Function & Vascular Volume 26. Renin & Angiotensin 27. Treatment of Myocardial Ischemia & Hypertension 28. Pharmacotherapy of Congestive Heart Failure 29. Anti-Arrhythmic Drugs 30. Blood Coagulation & Anticoagulant, Fibrinolytic & AntiplateletDrugs 31. Drug Therapy for Hypercholesterolemia & Dyslipidemia 32. Histamine, Bradykinin & Their Antagonists 33. Lipid-Derived Autacoids: Eicosanoids & Platelet-Activating Factor 34. Anti-inflammatory, Antipyretic & Analgesic Agents;Pharmacotherapy of Gout 35. Immunosuppressants, Tolerogens & Immunostimulants 36. Pulmonary Pharmacology 37. Hematopoietic Agents: Growth Factors, Minerals & Vitamins 38. Introduction To Endocrinology: The Hypothalamic-Pituitary Axis 39. Thyroid & Anti-Thyroid Drugs 40. Estrogens & Progestins 41. Androgens 42. ACTH, Adrenal Steroids & Pharmacology of the Adrenal Cortex 43. Endocrine Pancreas & Pharmacotherapy of Diabetes Mellitus &Hypoglycemia 44. Agents Affecting Mineral Ion Homeostasis & Bone Turnover 45. Pharmacotherapy of Gastric Acidity, Peptic Ulcers &Gastroesophageal Reflux Disease 46. Treatment of Disorders of Bowel Motility & Water Flux; Anti-Emetics; Agents Used in Biliary & Pancreatic Disease 47. Pharmacotherapy of Inflammatory Bowel Disease 48. General Principles of Antimicrobial Therapy
49. Chemotherapy of Malaria 50. Chemotherapy of Protozoal Infections: Amebiasis, Giardiasis,Trichomoniasis, Trypanosomiasis, Leishmaniasis & Other ProtozoalInfections 51. Chemotherapy of Helminth Infections 52. Sulfonamides, Trimethoprim-Sulfamethoxazole, Quinolones &Agents for UrinaryTract Infections 53. Penicillins, Cephalosporins & Other Beta-Lactam Antibiotics 54. Aminoglycosides 55. Protein Synthesis Inhibitors & Miscellaneous Antibacterial Agents 56. Chemotherapy of Tuberculosis, Mycobacterium Avium ComplexDisease & Leprosy 57. Antifungal Agents 58. Antiviral Agents (Nonretroviral) 59. Antiretroviral Agents & Treatment of HIV Infection 60. General Principles of Cancer Chemotherapy 61. Cytotoxic Agents 62. Targeted Therapies: Tyrosine Kinase Inhibitors, MonoclonalAntibodies & Cytokines 63. Natural Products in Cancer Chemotherapy: Hormones & RelatedAgents 64. Ocular Pharmacology 65. Dermatological Pharmacology 66. Contraception & Pharmacotherapy of Obstetrical & GynecologicalDisorders 67. Environmental Toxicology: Carcinogens & Heavy Metals I. Principles of Prescription Order Writing & Patient Compliance II. Design & Optimization of Dosage Regimens: Pharmacokinetic Data
Preface The publication of the twelfth edition of this book is a testament to thevision and ideals of the original authors, Alfred Gilman and LouisGoodman, who, in 1941 set forth the principles that have guided the bookthrough eleven editions: to correlate pharmacology with related medicalsciences, to reinterpret the actions and uses of drugs in light of advancesin medicine and the basic biomedical sciences, to emphasize theapplications of pharmacodynamics to therapeutics, and to create a bookthat will be useful to students of pharmacology and to physicians. Theseprecepts continue to guide the current edition.
As with editions since the second, expert scholars have contributedindividual chapters. A multiauthored book of this sort grows by accretion,posing challenges to editors but also offering memorable pearls to thereader. Thus, portions of prior editions persist in the current edition, and Ihasten to acknowledge the contributions of previous editors and authors,many of whom will see text that looks familiar. However, this editiondiffers noticeably from its immediate predecessors. Fifty new scientists,including a number from outside the U.S., have joined as contributors,and all chapters have been extensively updated. The focus on basicprinciples continues, with new chapters on drug invention, molecularmechanisms of drug action, drug toxicity and poisoning, principles ofantimicrobial therapy, and pharmacotherapy of obstetrical andgynecological disorders. Figures are in full color. The editors havecontinued to standardize the organization of chapters; thus, studentsshould easily find the basic physiology, biochemistry, and pharmacologyset forth in regular type; bullet points highlight important lists within thetext; the clinician and expert will find details in extract type under clearheadings.
Online features now supplement the printed edition. The entire text,updates, reviews of newly approved drugs, animations of drug action, andhyperlinks to relevant text in the prior edition are available on theGoodman & Gilman section of McGraw-Hill's websites, AccessMedicine.comand AccessPharmacy.com. An Image Bank CD accompanies the book andmakes all tables and figures available for use in presentations.
The process of editing brings into view many remarkable facts, theories,and realizations. Three stand out: the invention of new classes of drugshas slowed to a trickle; therapeutics has barely begun to capitalize on theinformation from the human genome project; and, the development ofresistance to antimicrobial agents, mainly through their overuse in
medicine and agriculture, threatens to return us to the pre-antibiotic era.We have the capacity and ingenuity to correct these shortcomings.
Many, in addition to the contributors, deserve thanks for their work onthis edition; they are acknowledged on an accompanying page. Inaddition, I am grateful to Professors Bruce Chabner (Harvard MedicalSchool/Massachusetts General Hospital) and Björn Knollmann (VanderbiltUniversity Medical School) for agreeing to be associate editors of thisedition at a late date, necessitated by the death of my colleague andfriend Keith Parker in late 2008. Keith and I worked together on theeleventh edition and on planning this edition. In anticipation of theeditorial work ahead, Keith submitted his chapters before anyone else andjust a few weeks before his death; thus, he is well represented in thisvolume, which we dedicate to his memory.
Laurence L. BruntonSan Diego, CaliforniaDecember 1, 2010
Goodman & Gilman's ThePharmacological Basis of Therapeutics,12th Edition
Preface to the Online Edition
The first edition of Goodman & Gilman's The PharmacologicalBasis of Therapeutics was published in 1941. Medicine haschanged dramatically since then; so, too, has the delivery ofinformation. The editors of the online version of 12th edition ofGoodman & Gilman are hoping to be at the forefront ofpublishing technology in a project to enhance the premier textin pharmacology and bring it to your desktop.We hope to bring not just the text of the book but to enhancethe text with additional features. The production of on-lineresources for Goodman & Gilman will be guided by threecomplementary priorities:
1. To provide regular updates, particularly in areas ofpharmacology and therapeutics where significant advancesin basic or clinical research have occurred since publicationof the printed version
2. To provide faculty and students with high-quality electronicresources to enhance teaching and learning ofpharmacology
3. To provide comprehensive search results that allow usersquick access to required content
We are currently working on the following online resources toenhance the 12th edition of Goodman & Gilman:
Updates: Regular updates, including new chapter content,a Clinical Pharmacist's Corner that discusses newlyapproved drugs or new therapeutic uses of approveddrugs, and pieces that focus on emerging areas ofpharmacological interest
Grand Rounds: Occasional webcasts of lectures in areas oftherapeutic importance by authorities
Multimedia Content: To complement the text, we have
1st
EditionTable ofContents
Page 1
Page 2
started an ongoing series of interactive, animated versionsof some of the more important figures from Goodman &Gilman, which are useful for interactive self-study bystudents
The Editors of Goodman & Gilman welcome your thoughts onimprovements and corrections to the text, as well assuggestions and submissions for online updates. If you are apharmacologist, pharmacist, physician, or medical scientist andyou would are interested to contribute an update, please sendan email to the Editors at [email protected].
The ENIAC (Electronical Numerical Integrator andComputer; circa 1945) was the first electronic computer.The invention of Dr. J. W. Mauchly and Mr. J. Presper Eckert, itcontainied close to 18,000 vacuum tubes, occupied a room 30by 50 feet, weighed 30 tons and cost of more than $486,000.It was used at the War Department's Ballistics ResearchLaboratory to calculate artillery trajectories. (U.S. Army Photo,courtesy of http://ftp.arl.army.mil/~mike/comphist/ andhttp://ftp.arl.army.mil/ftp/historic-computers/.)
Page 3
Page 4
Page 5
Copyright Information Goodman and Gilman's The Pharmacological Basis of Therapeutics,Twelfth Edition
Copyright © 2011, 2006, 2001, 1996, 1990, 1985, 1980, 1975, 1970,1965, 1955, 1941 by The McGraw-Hill Companies, Inc. All rights reserved.Printed in China. Except as permitted under the United States CopyrightAct of 1976, no part of this publication may be reproduced or distributedin any form or by any means, or stored in a database or retrieval system,without the prior written permission of the publisher.
ISBN 978-0-07-162442-8MHID 0-07-162442-2
Notice
Medicine is an ever-changing science. As new research and clinicalexperience broaden our knowledge, changes in treatment and drugtherapy are required. The authors and the publisher of this work havechecked with sources believed to be reliable in their efforts to provideinformation that is complete and generally in accord with the standardsaccepted at the time of publication. However, in view of the possibility ofhuman error or changes in medical sciences, neither the authors nor thepublisher nor any other party who has been involved in the preparation orpublication of this work warrants that the information contained herein isin every respect accurate or complete, and they disclaim all responsibilityfor any errors or omissions or for the results obtained from use of theinformation contained in this work. Readers are encouraged to confirm theinformation contained herein with other sources. For example and inparticular, readers are advised to check the product information sheetincluded in the package of each drug they plan to administer to be certainthat the information contained in this work is accurate and that changeshave not been made in the recommended dose or in the contraindicationsfor administration. This recommendation is of particular importance inconnection with new or infrequently used drugs.
Contributors
EditorLaurence L. Brunton, PhDProfessor of Pharmacology and MedicineSchool of Medicine, University of California, San DiegoLa Jolla, California
Associate EditorsBruce A. Chabner, MDProfessor of MedicineHarvard Medical SchoolDirector of Clinical ResearchMassachusetts General Hospital Cancer CenterBoston, Massachusetts
Björn C. Knollmann, MD, PhDProfessor of Medicine and PharmacologyOates Institute for Experimental TherapeuticsDivision of Clinical PharmacologyVanderbilt University School of MedicineNashville, Tennessee
Contributors (print)Edward P. Acosta, PharmDProfessor of Clinical PharmacologyUniversity of Alabama, Birmingham
Peter J. Barnes, DM, DSc, FRCP, FMedSci, FRSProfessor and Head of Respiratory MedicineNational Heart & Lung InstituteImperial College, London
Jeffrey A. Barnes, MD, PhDFellow in Hematology-OncologyDana-Farber Cancer InstituteBoston, Massachusetts
Leslie Z. Benet, PhDProfessor of Bioengineering and Therapeutic Sciences
Schools of Pharmacy and MedicineUniversity of California, San Francisco
John E. Bennett, MDChief of Clinical MycologyNational Institute of Allergy and Infectious DiseasesBethesda, Maryland
William Bennett, MDProfessor (Emeritus) of Medicine and PharmacologyOregon Health & Science University, Portland
Thomas P. Bersot, MD, PhDProfessor of Medicine; Associate InvestigatorGladstone Institute of Cardiovascular DiseaseUniversity of California, San Francisco
Joseph R. Bertino, MDProfessor of Medicine and PharmacologyRobert Wood Johnson Medical SchoolUniversity of Medicine & Dentistry of New JerseyNew Brunswick
Donald K. Blumenthal, PhDAssociate Professor of Pharmacology & ToxicologyCollege of PharmacyUniversity of Utah, Salt Lake City
Viengngeun Bounkeua, PhDMedical Scientist Training Program, School of MedicineUniversity of California, San Diego
Gregory A. Brent, MDProfessor of Medicine and PhysiologyGeffen School of MedicineUniversity of California, Los Angeles
Joan Heller Brown, PhDProfessor and Chair of PharmacologyUniversity of California, San Diego
Craig N. Burkhart, MDAssistant Professor of Dermatology, School of Medicine
University of North Carolina, Chapel Hill
Iain L. O. Buxton, PharmDProfessor of PharmacologyUniversity of Nevada School of Medicine, Reno
Michael C. Byrns, PhDFellow in PharmacologyUniversity of Pennsylvania School of Medicine, Philadelphia
William A. Catterall, PhDProfessor and Chair of PharmacologyUniversity of Washington School of Medicine, Seattle
Bruce A. Chabner, MDProfessor of Medicine, Harvard Medical SchoolDirector of Clinical Research, Massachusetts General Hospital CancerCenterBoston, Massachusetts
Henry F. Chambers, MDProfessor of Medicine and Chief of Infectious DiseasesSan Francisco General HospitalUniversity of California, San Francisco
Jérôme Clain, PharmD, PhDResearch Fellow in Microbiology and ImmunologyCollege of Physicians and SurgeonsColumbia University, New York
James M. Cleary MD, PhDAttending PhysicianDana-Farber Cancer InstituteBoston, Massachusetts
Michael W.H. Coughtrie, PhDProfessor of Biochemical PharmacologyDivision of Medical SciencesUniversity of Dundee, Scotland
David D'Alessio, MDProfessor of Endocrinology and MedicineUniversity of Cinncinnati, Ohio
Richard T. Eastman, PhDFellow in MicrobiologyColumbia University, New York
Ervin G. Erdös, MDProfessor (Emeritus) of PharmacologyUniversity of Illinois-Chicago
David A. Fidock, PhDAssociate Professor of Microbiology and MedicineCollege of Physicians and SurgeonsColumbia University, New York
Garret A. FitzGerald, MDProfessor of Medicine, Pharmacology and TranslationalMedicine and TherapeuticsChair of PharmacologyUniversity of Pennsylvania School of Medicine, Philadelphia
Charles W. Flexner, MDProfessor of Medicine, Pharmacology and Molecular Sciences, andInternational HealthThe Johns Hopkins University School of Medicine and Bloomberg School ofPublic HealthBaltimore, Maryland
Peter A. Friedman, PhDProfessor of Pharmacology and Chemical Biology School of MedicineUniversity of Pittsburgh, Pennsylvania
John W. Funder, AO, MD, BS, PhD, FRACPProfessor of Medicine, Prince Henry's InstituteMonash Medical CentreClaytonVictoria, Australia
James C. Garrison, PhDProfessor of Pharmacology, School of MedicineUniversity of Virginia, Charlottesville
Kathleen M. Giacomini, PhDProfessor and Chair of Biopharmaceutical Sciences School of PharmacyUniversity of California, San Francisco
Alfred G. Gilman, MD, PhDProfessor (Emeritus) of PharmacologyUniversity of Texas Southwestern Medical SchoolChief Scientific Officer, Cancer Prevention and Research Institute ofTexas, Dallas
Lowell A. Goldsmith, MD, MPHProfessor of Dermatology, School of MedicineUniversity of North Carolina, Chapel Hill, North Carolina
Frank J. Gonzalez, PhDChief, Laboratory of MetabolismCenter for Cancer Research, National Cancer InstituteBethesda, Maryland
Tilo Grosser, MDAssistant Professor of PharmacologyInstitute for Translational Medicine and TherapeuticsUniversity of Pennsylvania, Philadelphia
Tawanda Gumbo, MDAssociate Professor of Internal MedicineUniversity of Texas Southwestern Medical School, Dallas
Stephen R. Hammes, MD, PhDProfessor of Medicine, Chief of Endocrinology and MetabolismSchool of Medicine and DentistryUniversity of Rochester, New York
R. Adron Harris, PhDProfessor of Molecular Biology; Director, Waggoner Center for Alcohol andAddiction ResearchUniversity of Texas, Austin
Lisa A. Hazelwood, PhDResearch Fellow, Molecular Neuropharmacology SectionNational Institute of Neurological Disorders and StrokeBethesda, Maryland
Jeffrey D. Henderer, MDProfessor and Chair of OphthalmologyTemple University School of Medicine
Philadelphia, Pennsylvania
Ryan E. Hibbs, PhDResearch Fellow, Vollum InstituteOregon Health & Science University, Portland
Randa Hilal-Dandan, PhDLecturer in PharmacologyUniversity of California, San Diego
Brian B. Hoffman, MDProfessor of Medicine, Harvard Medical SchoolPhysician, VA-Boston Health Care SystemBoston, Massachusetts
Peter J. Hotez, MD, PhDProfessor and Chair of Microbiology, Immunology, and Tropical MedicineGeorge Washington University Washington, DC
Nina Isoherranen, PhDAssistant Professor of Pharmaceutics, School of PharmacyUniversity of Washington, Seattle
Edwin K. Jackson, PhDProfessor of Pharmacology and Chemical Biology School of MedicineUniversity of Pittsburgh, Pennsylvania
Allen P. Kaplan, MDClinical Professor of MedicineMedical University of South Carolina, Charleston
Robert S. Kass, PhDProfessor and Chair of Pharmacology Vice Dean for ResearchCollege of Physicians and Surgeons Columbia University, New York
Kenneth Kaushansky, MDDean, School of Medicine and Senior Vice President of Health SciencesSUNY Stony Brook, New York
Thomas J. Kipps, MD, PhDProfessor of Medicine, Moores Cancer CenterUniversity of California, San Diego
Ronald J. Koenig, MD, PhDProfessor of Metabolism, Endocrinology and DiabetesDepartment of Internal MedicineUniversity of Michigan Health System, Ann Arbor
Alan M. Krensky, MDSenior Investigator, National Cancer Institute, Bethesda, Maryland
Nora Laiken, PhDLecturer in Pharmacology and MedicineUniversity of California, San Diego
Andrew A. Lane, MD, PhDFellow, Dana-Farber Cancer InstituteMassachusetts General Hospital Cancer Center, Boston
Richard J. Lee, MD, PhDProfessor of Medicine, Harvard Medical SchoolPhysician, Massachusetts General HospitalBoston, Massachusetts
Ellis R. Levin, MDProfessor of Medicine; Chief of EndocrinologyDiabetes and MetabolismUniversity of California, Irvine, and Long BeachVA Medical Center, Long Beach
Dan L. Longo, MDScientific Director, National Institute on AgingNational Institutes of Health, Bethesda, Maryland
Alex Loukas, PhDProfessor of Public Health, Tropical Medicine and Rehabilitation SciencesJames Cook University, Cairns, Australia
Conan MacDougall, PharmD, MASAssociate Professor of Clinical Pharmacy School of PharmacyUniversity of California, San Francisco
Kenneth P. Mackie, MDProfessor of NeuroscienceIndiana University, Bloomington
Bradley A. Maron, MDFellow in Cardiovascular MedicineHarvard Medical School and Brigham and Women's HospitalBoston, Massachusetts
James McCarthy, MDAssociate Professor of Clinical Tropical MedicineUniversity of QueenslandBrisbane, Australia
James O. McNamara, MDProfessor and Chair of NeurobiologyDirector of Center for Translational NeuroscienceDuke University Medical CenterDurham, North Carolina
Jonathan M. Meyer, MDAssistant Adjunct Professor of PsychiatryUniversity of California, San Diego
Thomas Michel, MD, PhDProfessor of Medicine and Biochemistry Harvard Medical SchoolSenior Physician in Cardiovascular Medicine Brigham and Women'sHospitalBoston, Massachusetts
S. John Mihic, PhDProfessor of NeurobiologyWaggoner Center for Alcohol & Addiction ResearchInstitute for Neuroscience and Cell & Molecular BiologyUniversity of Texas, Austin
Constantine S. Mitsiades, MD, PhDProfessor of Medical OncologyDana-Farber Cancer Institute, Harvard Medical SchoolBoston, Massachusetts
Perry Molinoff, MDProfessor of Pharmacology, School of MedicineUniversity of Pennsylvania, Philadelphia
Dean S. Morrell, MDAssociate Professor of Dermatology
University of North Carolina, Chapel Hill
Beverly Moy, MD, MPHAssistant Professor of MedicineHarvard Medical SchoolMassachusetts General Hospital, Needham
Hamza Mujagic, MD, MR. SCI, DR. SCIVisiting Professor of Hematology and OncologyHarvard Medical SchoolMassachusetts General Hospital, Needham
Joel W. Neal, MD, PhDAssistant Professor of Medicine-Oncology, Stanford University School ofMedicine, Palo Alto, California
Charles P. O'Brien, MD, PhDProfessor of Psychiatry, School of MedicineUniversity of Pennsylvania, Philadelphia
James O'Donnell, PhDProfessor of Behavioral Medicine and Psychiatry School of MedicineWest Virginia University, Morgantown
Erin M. Olson, MDFellow in Medical OncologyDana-Farber Cancer InstituteBoston, Massachusetts
Taylor M. Ortiz, MDClinical Fellow in Medical OncologyDana-Farber Cancer InstituteGeneral Hospital Cancer CenterBoston, Massachusetts
Kevin Osterhoudt, MD, MSCE, FAAP, FACMTAssociate Professor of Pediatrics School of Medicine, University ofPennsylvaniaMedical Director, Poison Control Center, Children's Hospital ofPhiladelphia, Pennsylvania
Keith L. Parker, MD, PhD (deceased)Professor of Internal Medicine and Pharmacology
Chief of Endocrinology and MetabolismUniversity of Texas Southwestern Medical School, Dallas
Hemal H. Patel, PhDAssociate Professor of AnesthesiologyUniversity of California, San Diego Dean, School of Medicine and SeniorVice President of Health SciencesSUNY Stony Brook, New York
Piyush M. Patel, MD, FRCPCProfessor of AnesthesiologyUniversity of California, San Diego
Trevor M. Penning, PhDProfessor of PharmacologyDirector, Center of Excellence in Environmental Toxicology School ofMedicineUniversity of Pennsylvania, Philadelphia
William A. Petri, Jr, MD, PhDProfessor of Medicine; Chief, Division of Infectious DiseasesUniversity of Virginia, Charlottesville
Margaret A. Phillips, PhDProfessor of PharmacologyUniversity of Texas Southwestern Medical School, Dallas
Alvin C. Powers, MDProfessor of Medicine, Molecular Physiology and BiophysicsVanderbilt University Medical CenterNashville, Tennessee
Christopher Rapuano, MDDirector, Cornea Service and Refractive SurgeryDepartment, Wills Eye InstitutePhiladelphia, Pennsylvania
Robert F. Reilly, Jr, MDProfessor of Internal MedicineUniversity of Texas Southwestern Medical School, DallasChief of NephrologyVA-North Texas Health Care System, Dallas
Mary V. Relling, PharmDChair of Pharmaceutical SciencesSt. Jude Childrens' Research HospitalMemphis, Tennessee
Paul G. Richardson, MDAssociate Professor of Medicine, Harvard Medical SchoolClinical Director, Lipper Center for Multiple MyelomaDana-Farber Cancer InstituteBoston, Massachusetts
Suzanne M. Rivera, PhD, MSWAssistant Professor of Clinical SciencesUniversity of Texas Southwestern Medical Center, Dallas
Erik Roberson, MD, PhDAssistant Professor of Neurology and NeurobiologyUniversity of Alabama, Birmingham
Thomas P. Rocco, MDAssociate Professor of MedicineHarvard Medical SchoolVA-Boston Healthcare SystemBoston, Massachusetts
David M. Roth, MD, PhDProfessor of AnesthesiologyUniversity of California, San DiegoVA-San Diego Healthcare System
David P. Ryan, MDAssociate Professor of MedicineHarvard Medical SchoolMassachusetts General Hospital Cancer Center, Boston
Kevin J. Sampson, PhDPostdoctoral Research Scientist in PharmacologyColumbia University, New York
Elaine Sanders-Bush, PhDProfessor (Emerita) of PharmacologySchool of Medicine, Vanderbilt UniversityNashville, Tennessee
Bernard P. Schimmer, PhDProfessor (Emeritus) of Medical Research and PharmacologyUniversity of Toronto, Ontario
Marc A. Schuckit, MDDistinguished Professor of PsychiatryUniversity of California, San DiegoDirector, Alcohol Research CenterVA-San Diego Healthcare System
Lecia Sequist, MD, MPHAssistant Professor of MedicineHarvard Medical School, Massachusetts General Hospital Cancer Center,Boston
Keith A. Sharkey, PhDProfessor of Physiology & Pharmacology and MedicineUniversity of Calgary, Alberta
Richard C. Shelton, MDProfessor of Psychiatry and PharmacologySchool of Medicine, Vanderbilt UniversityNashville, Tennessee
Danny Shen, PhDProfessor and Chair of PharmacyProfessor of Pharmaceutics, School of PharmacyUniversity of Washington, Seattle
Randal A. Skidgel, PhDProfessor of Pharmacology and AnesthesiologyCollege of Medicine, University of Illinois-Chicago
Matthew R. Smith, MD, PhDAssociate Professor of Medicine, Harvard Medical SchoolPhysician, Massachusetts General Hospital, Boston
Emer M. Smyth, PhDResearch Assistant, Professor of PharmacologyUniversity of Pennsylvania, Philadelphia
Peter J. Snyder, MD
Professor of MedicineUniversity of Pennsylvania, Philadelphia
David Standaert, MD, PhDProfessor of NeurologyDirector, Center for Neurodegeneration and Experimental TherapeuticsUniversity of Alabama, Birmingham
Samuel L. Stanley, Jr, MDProfessor of Medicine and PresidentSUNY Stony Brook, New York
Yuichi Sugiyama, PhDProfessor and Chair of Molecular PharmacokineticsUniversity of Tokyo, Japan
Jeffrey G. Supko, PhDAssociate Professor of Medicine, Harvard Medical SchoolMassachusetts General Hospital, Boston
Palmer W. Taylor, PhDProfessor of Pharmacology, School of MedicineDean, Skaggs School of Pharmacy and Pharmaceutical SciencesUniversity of California, San Diego
Kenneth E. Thummel, PhDProfessor and Chair, Department of PharmaceuticsUniversity of Washington, Seattle
Robert H. Tukey, PhDProfessor of Pharmacology and Chemistry/BiochemistryUniversity of California, San Diego
Flavio Vincenti, MDProfessor of Clinical MedicineMedical Director, Pancreas Transplant ProgramUniversity of California, San Francisco
Joseph M. Vinetz, MDProfessor of Medicine, Division of Infectious DiseasesUniversity of California, San Diego
Mark S. Wallace, MD
Professor of Clinical AnesthesiologyUniversity of California, San Diego
John L. Wallace, PhD, MBA, FRSCProfessor and Director, Farncombe Family Digestive Health ResearchInstituteMcMaster University, Hamilton, Ontario
Jeffrey I. Weitz, MD, FRCP(C), FACPProfessor of Medicine, Biochemistry and Biomedical Sciences McMasterUniversityExecutive Director, Thrombosis & AtherosclerosisResearch Institute, Hamilton, Ontario
David P. Westfall, PhDProfessor (Emeritus) of PharmacologyUniversity of Nevada School of Medicine, Reno
Thomas C. Westfall, PhDProfessor and Chair of Pharmacological and Physiological ScienceSt. Louis University School of Medicine, Missouri
Wyndham Wilson, MD, PhDSenior Investigator and Chief of Lymphoid Therapeutics SectionCenter for Cancer Research, National Cancer InstituteBethesda Maryland
Tony L. Yaksh, PhDProfessor of Anesthesiology and PharmacologyUniversity of California, San Diego
Alexander C. Zambon, PhDAssistant Professor of PharmacologyUniversity of California, San Diego
Contributors (online)
Editor-in-Chief
Laurence L. Brunton
Associate Editors
Donald K. Blumenthal
Nelda Murri
Randa Hilal-DandanLecturer in PharmacologyUniversity of California, San Diego
Consulting Editor
Björn C. Knollmann
Preface Preface to the Online Edition Copyright Contributors
Section I. General Principles
Chapter 1 Drug Invention & the Pharmaceutical Industry
Chapter 2 Pharmacokinetics: The Dynamics of Drug Absorption, Distribution, Metabolism &Elimination
Chapter 3 Pharmacodynamics: Molecular Mechanisms of Drug Action
Chapter 4 Drug Toxicity & Poisoning
Chapter 5 Membrane Transporters & Drug Response
Chapter 6 Drug Metabolism
Chapter 7 Pharmacogenetics
Section II. Neuropharmacology
Chapter 8 Neurotransmission: The Autonomic & Somatic Motor Nervous Systems
Chapter 9 Muscarinic Receptor Agonists & Antagonists
Chapter 10 Anticholinesterase Agents
Chapter 11 Agents Acting at the Neuromuscular Junction & Autonomic Ganglia
Chapter 12 Adrenergic Agonists & Antagonists
Chapter 13 5-Hydroxytryptamine (Serotonin) & Dopamine
Chapter 14 Neurotransmission & the Central Nervous System
Chapter 15 Drug Therapy of Depression & Anxiety Disorders
Chapter 16 Pharmacotherapy of Psychosis & Mania
Chapter 17 Hypnotics & Sedatives
Chapter 18 Opioids, Analgesia & Pain Management
Chapter 19 General Anesthetics & Therapeutic Gases
Chapter 20 Local Anesthetics
Chapter 21 Pharmacotherapy of the Epilepsies
Chapter 22 Treatment of Central Nervous System Degenerative Disorders
Chapter 23 Ethanol & Methanol
Chapter 24 Drug Addiction
Section III. Modulation of Cardiovascular Function
Chapter 25 Regulation of Renal Function & Vascular Volume
Chapter 26 Renin & Angiotensin
Chapter 27 Treatment of Myocardial Ischemia & Hypertension
Chapter 28 Pharmacotherapy of Congestive Heart Failure
Chapter 29 Anti-Arrhythmic Drugs
Chapter 30 Blood Coagulation & Anticoagulant, Fibrinolytic & Antiplatelet Drugs
Chapter 31 Drug Therapy for Hypercholesterolemia & Dyslipidemia
Section IV. Inflammation, Immunomodulation & Hematopoiesis
Chapter 32 Histamine, Bradykinin & Their Antagonists
Chapter 33 Lipid-Derived Autacoids: Eicosanoids & Platelet-Activating Factor
Chapter 34 Anti-inflammatory, Antipyretic & Analgesic Agents; Pharmacotherapy of Gout
Chapter 35 Immunosuppressants, Tolerogens & Immunostimulants
Chapter 36 Pulmonary Pharmacology
Chapter 37 Hematopoietic Agents: Growth Factors, Minerals & Vitamins
Section V. Hormones & Hormone Antagonists
Chapter 38 Introduction To Endocrinology: The Hypothalamic-Pituitary Axis
Chapter 39 Thyroid & Anti-Thyroid Drugs
Chapter 40 Estrogens & Progestins
Chapter 41 Androgens
Chapter 42 ACTH, Adrenal Steroids & Pharmacology of the Adrenal Cortex
Chapter 43 Endocrine Pancreas & Pharmacotherapy of Diabetes Mellitus & Hypoglycemia
Chapter 44 Agents Affecting Mineral Ion Homeostasis & Bone Turnover
Section VI. Drugs Affecting Gastrointestinal Function
Chapter 45 Pharmacotherapy of Gastric Acidity, Peptic Ulcers & Gastroesophageal RefluxDisease
Chapter 46 Treatment of Disorders of Bowel Motility & Water Flux; Anti-Emetics; AgentsUsed in Biliary & Pancreatic Disease
Chapter 47 Pharmacotherapy of Inflammatory Bowel Disease
Section VII. Chemotherapy of Microbial Diseases
Chapter 48 General Principles of Antimicrobial Therapy
Chapter 49 Chemotherapy of Malaria
Chapter 50 Chemotherapy of Protozoal Infections: Amebiasis, Giardiasis, Trichomoniasis,Trypanosomiasis, Leishmaniasis & Other Protozoal Infections
Chapter 51 Chemotherapy of Helminth Infections
Chapter 52 Sulfonamides, Trimethoprim-Sulfamethoxazole, Quinolones & Agents forUrinaryTract Infections
Chapter 53 Penicillins, Cephalosporins & Other β-Lactam Antibiotics
Chapter 54 Aminoglycosides
Chapter 55 Protein Synthesis Inhibitorsand Miscellaneous Antibacterial Agents
Chapter 56 Chemotherapy of Tuberculosis, Mycobacterium Avium Complex Disease & Leprosy
Chapter 57 Antifungal Agents
Chapter 58 Antiviral Agents (Nonretroviral)
Chapter 59 Antiretroviral Agents & Treatment of HIV Infection
Section VIII. Chemotherapy of Neoplastic Diseases
Chapter 60 General Principles of Cancer Chemotherapy
Chapter 61 Cytotoxic Agents
Chapter 62 Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies &Cytokines
Chapter 63 Natural Products in Cancer Chemotherapy: Hormones & Related Agents
Section IX. Special Systems Pharmacology
Chapter 64 Ocular Pharmacology
Chapter 65 Dermatological Pharmacology
Chapter 66 Contraception & Pharmacotherapy of Obstetrical & Gynecological Disorders
Chapter 67 Environmental Toxicology: Carcinogens & Heavy Metals
Section X. Appendices
Appendix I Principles of Prescription Order Writing & PatientCompliance
Appendix II Design & Optimization of Dosage Regimens:Pharmacokinetic Data